The Future of Non-Dilutive Funding in an AI World
Reception & Executive Briefing
As artificial intelligence rapidly transforms the life sciences landscape, organizations must rethink how they compete for funding, communicate innovation, and accelerate commercialization. In this executive briefing, Dr. Eva Garland will explore how AI is reshaping the future of non-dilutive funding and what companies can do today to position themselves for success.
The program will feature a 30-minute executive briefing led by Dr. Garland followed by an intimate reception with cocktails and hors d’oeuvres. Attendees will gain a clear view of how AI is impacting competitive positioning and proposal strategy, along with practical insights to strengthen funding and growth strategies.
June 23, 2026 | 7:00 PM – 9:00 PM
The Westin San Diego Bayview | San Diego, CA
Discussion Topics
- How AI is changing the way funding agencies evaluate proposals and prioritize investments
- Strategies for standing out in an increasingly competitive environment competing for more than $100 billion in early-stage non-dilutive funding
- Emerging trends shaping the future of fundraising, innovation, and commercialization
- Practical approaches for leveraging AI while maintaining a compelling scientific and business narrative
Following the presentation, attendees will have the opportunity to connect with fellow innovators, entrepreneurs, investors, and industry leaders during a networking reception hosted by the EGC team.
We look forward to welcoming members of the life sciences community for an evening of insight, discussion, and meaningful connections during BIO Week.
EGC partners with innovative organizations to secure and manage non-dilutive funding from federal and private sources. With more than $2B raised across thousands of grants and contracts, EGC has supported over 5,000 clients worldwide—including startups, established companies, universities, and government agencies—to advance breakthrough technologies through commercialization.